The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Antidepressant disposition can be influenced by a variety of CYP isozymes and their effects in the treatment of depression are reviewed. The CYP isozymes 2D6, 3A4, 1A2 and 2C are discussed in regard to antidepressant drug pharmacokinetics, clinical relevance and variability in activity for each isozyme. Polymorphism has been identified with CYP 2D6 and 2C19. Disposition of antidepressants which are substrates of these two isozymes can also be influenced and contributes towards the wide interpatient and interethnic variability found with these drugs. Antidepressants (especially SSRIs) can be CYP isozyme inhibitors and produce significant drug-drug interactions.

Original languageEnglish
Pages (from-to)39-67
Number of pages29
JournalDrug Metabolism and Drug Interactions
Volume16
Issue number1
DOIs
StatePublished - 2000

Keywords

  • Antidepressants
  • CYP isozymes
  • Drug interactions
  • Ethnicity
  • Metabolism

Fingerprint Dive into the research topics of 'The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression'. Together they form a unique fingerprint.

  • Cite this